As an emerging drug carrier, hydrogels have been widely used for tumor drug delivery. A
hydrogel drug carrier can cause less severe side effects than systemic chemotherapy and …

Breast cancer, specifically metastatic breast, is a leading cause of morbidity and mortality in
women. This is mainly due to relapse and reoccurrence of tumor. The primary reason for …

Poor water solubility, off-target toxicity, and small therapeutic window are among major
obstacles for the development of drug products. Redox-responsive drug delivery …

Multidrug resistance (MDR) of cancer is a persistent problem in chemotherapy. Scientists
have considered the overexpressed efflux transporters responsible for MDR and …

Cancer is a genetic disease originating from the accumulation of gene mutations in a
cellular subpopulation. Although many therapeutic approaches have been developed to …

Hyaluronic acid (HA) is a naturally occurring polysaccharide which has been extensively
exploited in biomedical fields owing to its outstanding biocompatibility. Self‐assembly of HA …

Background Heterocyclic compounds have always been used as a core portion in the
development of anticancer drugs. However, there is a pressing need for developing …

Antitumor nanoparticles now confront several obstacles, including poor biocompatibility and
biodegradability, quick removal, and a short cycle time, given the growing interest in surface …

RNA interference is one of the emerging methodologies utilized in the treatment of a wide
variety of diseases including cancer. This method specifically uses therapeutic RNAs …

Over the past decade, DNA nanotechnology has developed rapidly due to its unique
characteristics, such as excellent biocompatibility, high programmability, good predictability …